According to the latest State of Revenue survey of c-suite executives, pharma manufacturers are prioritizing digital transformation while struggling with inflation and supply chain disruptions.
Kyle Forcier
Advertisement
Kyle Forcier is the senior director of life sciences and product marketing for Model N.
Articles by Kyle Forcier
According to the 2023 State of Revenue Report, pharma companies are prioritizing digital transformation while struggling with inflation and supply chain disruptions.
Advertisement
Latest Updated Articles
An Inside Look at Pharma Revenue ManagementPublished: March 8th 2023 | Updated:
Advertisement
Advertisement
